Senores Pharmaceuticals will debut on the exchanges on Monday. Ahead of the listing, the company's shares were trading with a GMP of Rs 284 in the grey market.
Considering the upper price band of Rs 391, the stock is expected to list at a premium of 70% or above the issue price.
However, it is important to note that grey market premiums are just an indicator as to how the company's shares are stacked up in the unlisted market and are subject to change rapidly.
The IPO of Senores Pharmaceuticals received robust response from investors with an overall subscription of over 93.41 times at close.
At the upper price band, the company is valued at P/E of 55x with a market cap of Rs 1801 crore post issue of equity shares and return on net worth of 23.6% based on FY24.
Stock Trading
Masterclass on Value Investing and Company Valuation
By — The Economic Times, Get Certified By India's Top Business News Brand
Stock Trading
Market 104: Options Trading: Kickstart Your F&O Adventure
By — Saketh R, Founder- QuickAlpha, Full Time Options Trader
Stock Trading
Technical Analysis for Everyone — Technical Analysis Course
By — Abhijit Paul, Technical Research Head, Fund Manager- ICICI Securities
Stock Trading
Stock Markets Made Easy
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Renko Chart Patterns Made Easy
By — Kaushik Akiwatkar, Derivative Trader and Investor
Stock Trading
Market 101: An Insight into Trendlines and Momentum
By — Rohit Srivastava, Founder- Indiacharts.com
Stock Trading
Markets 102: Mastering Sentiment